Article Text
Abstract
In ethical and regulatory discussions on new applications of genomic testing technologies, the notion of ‘personal utility’ has been mentioned repeatedly. It has been used to justify direct access to commercially offered genomic testing or feedback of individual research results to research or biobank participants. Sometimes research participants or consumers claim a right to genomic information with an appeal to personal utility. As of yet, no systematic account of the umbrella notion of personal utility has been given. This paper offers a definition of personal utility that places it in the middle of the spectrum between clinical utility and personal perceptions of utility, and that acknowledges its normative charge. The paper discusses two perspectives on personal utility, the healthcare perspective and the consumer perspective, and argues that these are too narrow and too wide, respectively. Instead, it proposes a normative definition of personal utility that postulates information and potential use as necessary conditions of utility. This definition entails that perceived utility does not equal personal utility, and that expert judgment may be necessary to help determine whether a genomic test can have personal utility for someone. Two examples of genomic tests are presented to illustrate the discrepancies between perceived utility and our proposed definition of personal utility. The paper concludes that while there is room for the notion of personal utility in the ethical evaluation and regulation of genomic tests, the justificatory role of personal utility is not unlimited. For in the absence of clinical validity and reasonable potential use of information, there is no personal utility.
Statistics from Altmetric.com
Linked Articles
- Genetics
- Genetics
- Genetics
- The concise argument
Read the full text or download the PDF:
Other content recommended for you
- On the personal utility of Alzheimer’s disease-related biomarker testing in the research context
- Personal utility is inherent to direct-to-consumer genomic testing
- A practical guide to interpretation and clinical application of personal genomic screening
- Guideline for feedback of individual genetic research findings for genomics research in Africa
- Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial
- Impact of direct-to-consumer genomic testing at long term follow-up
- Defining and managing incidental findings in genetic and genomic practice
- Moral motivation regarding dementia risk testing among affected persons in Germany and Israel
- Clinical application of fetal genome-wide sequencing during pregnancy: position statement of the Canadian College of Medical Geneticists
- Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation